🇺🇸#premarket #сша
премаркет США - акции - заметные движения:
ВВЕРХ
#SCON +123% Superconductor Technologies Inc. -Superconductor Technologies and Allied Integral United announced a merger agreement.
#KMPH +25% KemPharm, Inc. - submitted KP415 NDA to the FDA for the treatment of ADHD.
#GNMK +22% GenMark Diagnostics, Inc - reported Q4 results.
#XAIR +21% Beyond Air, Inc. - after rising over 13% on Monday.
#QGEN +16% QIAGEN N.V. -Thermo Fisher Scientific Inc. #TMO
announced plans to acquire QIAGEN for 10.4 billion euros ($11.6 billion).
#NOVN +16% Novan, Inc. - after jumping around 113% on Monday.
#OMER +16% Omeros Corporation - reported Narsoplimab HSCT-TMA results surpassed the FDA-agreed efficacy threshold.
#WIFI +14% Boingo Wireless Inc - reported Q4 earnings.
#PHIO +13% Phio Pharmaceuticals Corp. - after gaining more than 5% on Monday.
#TRIL +10% Trillium Therapeutics Inc. - after surging over 26% on Monday.
#IBIO +10% iBio, Inc. - highlighted withdrawal of proxy statement proposal related to amend its certificate of incorporation to authorize possible reverse stock split.
#IPHA +8% Innate Pharma S.A. -after gaining 13% on Monday.
#PLUG +7% Plug Power Inc.
#BLDP +7% Ballard Power Systems Inc. - after jumping about 13% on Monday.
#BYND +5% Beyond Meat, Inc. - after jumping over 7% on Monday.
#SPCE +5% Virgin Galactic Holdings, Inc. - after gaining around 6% on Monday.
#GNFT +5% Genfit SA
#LVGO +5% Livongo Health Inc - reported better-than-expected Q4 sales. The company also issued Q1 and FY20 sales guidance above estimates.
#DAL +5% Delta Air Lines, Inc.
#SE +5% Sea Ltd - following Q4 results.
#FSLY +5% Fastly, Inc.
#AAL +4% American Airlines Group Inc.
#TMO +3% Thermo Fisher Scientific Inc. - announced plans to acquire QIAGEN for 10.4 billion euros ($11.6 billion).
ВНИЗ
#CPHI -24% China Pharma Holdings, Inc. - shares jumped 100% on Monday after the company announced a wash-free sanitizer in response to the coronavirus.
#RTTR -18% Ritter Pharmaceuticals, Inc. - after slipping over 11% on Monday.
#APDN -17% Applied DNA Sciences, Inc. - after rising around 30% on Monday.
#CODX -16% Co-Diagnostics, Inc. - shares gained around 35% on Monday after the company announced it will provide COVID-19 tests to US CLIA labs.
#NOVN -14% Novan Inc - filed 14 million share common stock offering, including warrants.
#HTBX -15% Heat Biologics, Inc. - shares jumped more than 142% on Monday after the Durham, North, Carolina-based biopharma company said in an SEC filing that it has filed a provisional patent application that would apply its immune system activating technology for the treatment or prevention ofCOVID-19, the new coronavirus originating from Wuhan, China.
#VIR -14% Vir Biotechnology, Inc.
#AHPI -14% Allied Healthcare Products, Inc. - after declining around 35% on Monday.
#NVAX -14% Novavax, Inc. -shares tumbled around 25% on Monday following news of a $150 million common stock offering via B. Riley FBR.
#LAKE -13% Lakeland Industries, Inc. -after dropping over 14% on Monday.
#TLRY -12% Tilray, Inc. -reported a net loss of $219.2 million, or $2.14 a share for the fourth quarter, versus a year-ago loss of $31 million or $0.33 per share. The company also reported worse-than-expected Q4 sales.
#APT -12% Alpha Pro Tech, Ltd. - after declining over 24% on Monday.
#ALT -11% Altimmune, Inc. - after declining about 15% on Monday.
#VXTR -10% Vaxart, Inc. -after dropping more than 18% on Monday.
#APPF -4% AppFolio Inc - issued FY20 sales guidance below estimates.
#KPTI -4% Karyopharm Therapeutics Inc - announced a proposed public offering of common stock of $150 million.
#EHTH -3% eHealth, Inc. - announced a 1.5 million share common stock offering.
премаркет США - акции - заметные движения:
ВВЕРХ
#SCON +123% Superconductor Technologies Inc. -Superconductor Technologies and Allied Integral United announced a merger agreement.
#KMPH +25% KemPharm, Inc. - submitted KP415 NDA to the FDA for the treatment of ADHD.
#GNMK +22% GenMark Diagnostics, Inc - reported Q4 results.
#XAIR +21% Beyond Air, Inc. - after rising over 13% on Monday.
#QGEN +16% QIAGEN N.V. -Thermo Fisher Scientific Inc. #TMO
announced plans to acquire QIAGEN for 10.4 billion euros ($11.6 billion).
#NOVN +16% Novan, Inc. - after jumping around 113% on Monday.
#OMER +16% Omeros Corporation - reported Narsoplimab HSCT-TMA results surpassed the FDA-agreed efficacy threshold.
#WIFI +14% Boingo Wireless Inc - reported Q4 earnings.
#PHIO +13% Phio Pharmaceuticals Corp. - after gaining more than 5% on Monday.
#TRIL +10% Trillium Therapeutics Inc. - after surging over 26% on Monday.
#IBIO +10% iBio, Inc. - highlighted withdrawal of proxy statement proposal related to amend its certificate of incorporation to authorize possible reverse stock split.
#IPHA +8% Innate Pharma S.A. -after gaining 13% on Monday.
#PLUG +7% Plug Power Inc.
#BLDP +7% Ballard Power Systems Inc. - after jumping about 13% on Monday.
#BYND +5% Beyond Meat, Inc. - after jumping over 7% on Monday.
#SPCE +5% Virgin Galactic Holdings, Inc. - after gaining around 6% on Monday.
#GNFT +5% Genfit SA
#LVGO +5% Livongo Health Inc - reported better-than-expected Q4 sales. The company also issued Q1 and FY20 sales guidance above estimates.
#DAL +5% Delta Air Lines, Inc.
#SE +5% Sea Ltd - following Q4 results.
#FSLY +5% Fastly, Inc.
#AAL +4% American Airlines Group Inc.
#TMO +3% Thermo Fisher Scientific Inc. - announced plans to acquire QIAGEN for 10.4 billion euros ($11.6 billion).
ВНИЗ
#CPHI -24% China Pharma Holdings, Inc. - shares jumped 100% on Monday after the company announced a wash-free sanitizer in response to the coronavirus.
#RTTR -18% Ritter Pharmaceuticals, Inc. - after slipping over 11% on Monday.
#APDN -17% Applied DNA Sciences, Inc. - after rising around 30% on Monday.
#CODX -16% Co-Diagnostics, Inc. - shares gained around 35% on Monday after the company announced it will provide COVID-19 tests to US CLIA labs.
#NOVN -14% Novan Inc - filed 14 million share common stock offering, including warrants.
#HTBX -15% Heat Biologics, Inc. - shares jumped more than 142% on Monday after the Durham, North, Carolina-based biopharma company said in an SEC filing that it has filed a provisional patent application that would apply its immune system activating technology for the treatment or prevention ofCOVID-19, the new coronavirus originating from Wuhan, China.
#VIR -14% Vir Biotechnology, Inc.
#AHPI -14% Allied Healthcare Products, Inc. - after declining around 35% on Monday.
#NVAX -14% Novavax, Inc. -shares tumbled around 25% on Monday following news of a $150 million common stock offering via B. Riley FBR.
#LAKE -13% Lakeland Industries, Inc. -after dropping over 14% on Monday.
#TLRY -12% Tilray, Inc. -reported a net loss of $219.2 million, or $2.14 a share for the fourth quarter, versus a year-ago loss of $31 million or $0.33 per share. The company also reported worse-than-expected Q4 sales.
#APT -12% Alpha Pro Tech, Ltd. - after declining over 24% on Monday.
#ALT -11% Altimmune, Inc. - after declining about 15% on Monday.
#VXTR -10% Vaxart, Inc. -after dropping more than 18% on Monday.
#APPF -4% AppFolio Inc - issued FY20 sales guidance below estimates.
#KPTI -4% Karyopharm Therapeutics Inc - announced a proposed public offering of common stock of $150 million.
#EHTH -3% eHealth, Inc. - announced a 1.5 million share common stock offering.
⚡️🇺🇸#QGEN #отчетность #прогноз
QIAGEN announces preliminary Q2 2021 results exceeding outlook, updates full-year 2021 outlook for declining COVID-19 test trends and plans new $100 million share repurchase program
Preliminary Q2 2021 results: Net sales up 28% (+24% CER) to $567.3 million, above ~+20% CER outlook; adj. EPS up ~21% to $0.66-0.67 ($0.65-0.66 CER) vs. ~$0.62-0.64 CER outlook
Very strong non-COVID product group sales: +52% CER growth in Q2 2021 to $407.6 million, representing 72% of total sales, expect at least 20% CER full-year growth
Updated full-year 2021 outlook due to impact of faster-than-expected uptake of COVID-19 vaccines on test demand: At least 12% CER sales growth and at least $2.42 CER adj. EPS
QIAGEN announces preliminary Q2 2021 results exceeding outlook, updates full-year 2021 outlook for declining COVID-19 test trends and plans new $100 million share repurchase program
Preliminary Q2 2021 results: Net sales up 28% (+24% CER) to $567.3 million, above ~+20% CER outlook; adj. EPS up ~21% to $0.66-0.67 ($0.65-0.66 CER) vs. ~$0.62-0.64 CER outlook
Very strong non-COVID product group sales: +52% CER growth in Q2 2021 to $407.6 million, representing 72% of total sales, expect at least 20% CER full-year growth
Updated full-year 2021 outlook due to impact of faster-than-expected uptake of COVID-19 vaccines on test demand: At least 12% CER sales growth and at least $2.42 CER adj. EPS